Do you want to read an article? Please log in or register.
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study
J Crohns Colitis
Privitera G, Bezzio C, Buono AD, Gabbiadini R, Loy L, Ranucci L, Bertin L, Masoni B, Migliorisi G, Sauta E, Delleani M, Savevski V, Porta MD, D'amico S, Armuzzi A
doi: 10.1093/ecco-jcc/jjaf239
Inflammatory Bowel Disease
Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis
Inflamm Bowel Dis
Desai A, Habib H, Khataniar H, Farraye FA, Sehgal P, Barnes EL, Kochhar GS, Hashash JG
doi: 10.1093/ibd/izaf301
Inflammatory Bowel DiseaseFurther Publications
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry
United European Gastroenterol J
Naber MR, van der Meulen AE, Voorneveld PW, Veltkamp SHC, van Bodegraven AA, Bodelier A, Mujagic Z, Pierik M, Verleye LMM, Duijvestein M, Bouwknegt DG, Visschedijk MC, Srivastava N, West RL, Oldenburg B, Löwenberg M, van Schaik FDM, Dutch ICC Registry
doi: 10.1002/ueg2.70141
Inflammatory Bowel Disease
Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from Australasia
Clin Gastroenterol Hepatol
Fernandes RG, Kim DH, Ruddick-Collins L, Vasudevan A, Brownson AR, Ngoi B, Lin CC, Haifer C, Kim DS, Swe E, Wright EK, Song EM, Mahy G, Moore GT, Lee HS, Kim HS, Zhang J, Yan Mak JW, Lee J, Lynch K, Gazelakis K, Rice K, Kim KO, Liu J, Lilian Bracken LM, Garg M, Schultz M, Clark N, Cao Q, Gilmore R, Park SH, Kim SJ, Sagami S, Wei SC, Kashkooli S, Schildkraut T, Lin WC, Hsu WH, Lee YJ, Kim ES, Begun J, Kobayashi T, An YK
doi: 10.1016/j.cgh.2025.10.019
Inflammatory Bowel Disease
Mirikizumab impact on disease clearance in patients with moderately to severely active ulcerative colitis: analysis of a pre-specified LUCENT trial endpoint
J Crohns Colitis
Colombel JF, Wu J, Kobayashi T, Zhu B, Paulissen J, Dhanabal A, Jairath V, Siegel C, Siegmund B, Redondo I, Moses R, Magro F
doi: 10.1093/ecco-jcc/jjaf124
Gastrointestinal CancerInflammatory Bowel Disease
Background Mucosal Inflammation Affects Colorectal Cancer Prognosis in Ulcerative Colitis: A Nationwide, Multicenter Study
J Crohns Colitis
Ikebata A, Okabayashi K, Uchino M, Ikeuchi H, Shigeta K, Oka S, Futami K, Itabashi M, Watanabe K, Shibutani M, Okita Y, Wakai T, Mizuuchi Y, Okamoto K, Yamada K, Sato Y, Ogino T, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Yamamoto T, Yamamoto S, Koyama F, Hanai T, Komori K, Shida D, Arakaki J, Akagi Y, Yamaguchi S, Ueno H, Matsuda K, Maemoto A, Nezu R, Sasaki S, Sunami E, Maeda K, Noake T, Hasegawa J, Kanemitsu Y, Katsumata K, Uehara K, Kiyomatsu T, Suto T, Kazama S, Yamada T, Goi T, Noguchi T, Ishihara S, Ajioka Y, Sugihara K
doi: 10.1093/ecco-jcc/jjaf207
RECOMMENDED
Inflammatory Bowel Disease
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Fuentes-Valenzuela E, Bastón-Rey I, García-Alonso FJ, Elosua A, Zabalza San Martín L, Leo Carnerero E, Garcia de la Filia I, Pedraza Pérez A, Sáiz Chumillas RM, Pascual Oliver A, Muñoz Villafranca C, Moreno V, Suárez Ferrer C, Molina G, Ferreiro-Iglesias R, Vega Villaamil P, Gardeazábal Mateos D, Segarra-Ortega JX, Garrido Marín A, Doallo AI, Alonso-Galán H, Brunet-Mas E, Jimenez García N, López Romero-Salazar F, Velayos B, Carballo-Folgoso L, Pérez Santamaría C, Mata Román L, Núñez Ortiz A, Barrio J, Barreiro-de Acosta M, Gutiérrez-Casbas A, Young GETECCU group
doi: 10.1093/ecco-jcc/jjaf058
Inflammatory Bowel Disease
Ulcerative colitis: moving beyond the mucosal dogma
Lancet Gastroenterol Hepatol
Eggermont E, Gecse K, Krugliak Cleveland N, Petersen F, Sabino J, D'Hoore A, Kucharzik T, Allocca M, Bislenghi G, Novak K, De Hertogh G, Maaser C, Verstockt B
doi: 10.1016/S2468-1253(25)00263-8
Inflammatory Bowel Disease
Placebo rates in randomised clinical trials of ulcerative colitis: An individual patient data meta-analysis
J Crohns Colitis
Solitano V, Hogan M, Singh S, Danese S, Peyrin-Biroulet L, Vuyyuru S, Macdonald JK, Zou G, Yuan Y, Sands BE, Panaccione R, Feagan BG, Hanzel J, Sedano R, Dulai P, Narula N, Ma C, Jairath V
doi: 10.1093/ecco-jcc/jjaf191